Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: Yahoo! Finance
Malte Peters, a physician with extensive oncology development and regulatory experience, became President and Chief Executive Officer. Alongside this leadership shift, the company reaffirmed its 2026 clinical milestones, highlighting continuity in its precision oncology pipeline as it moves vopimetostat and other programs through key trials. Next, we examine how Dr. Malte Peters' late-stage development background and the reaffirmed 2026 milestones could reshape Tango Therapeutics' investment narrative. These 16 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs . Discover why before your portfolio feels the trade war pinch. For Tango Therapeutics, the core investment case still rests on belief in its precision oncology platform, the potential of vopimetostat and newer assets like TNG456, and access to capital while the business remains loss-making. The recent leadership transition, with founding CEO Barbara Weber moving to Exec
Show less
Read more
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed SuccessorGlobeNewswire
- Tango Therapeutics Appoints Sung Lee to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Appoints Sung Lee to Board of DirectorsGlobeNewswire
- Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
TNGX
Earnings
- 11/4/25 - Beat
TNGX
Sec Filings
- 1/12/26 - Form 4
- 1/8/26 - Form 8-K
- 1/6/26 - Form 4
- TNGX's page on the SEC website